The effect of consumption of barberry fruit powder in type 2 diabetic patients
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20180811040758N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
People with type 2 diabetes are diagnosed
Exclusion Criteria
Pregnancy
Lactation
History of heart disease
History of heart failure in the last 3 months
heart attack
Acute and chronic hepatic disease, except fatty liver
Impaired kidney function
Hyperthyroidism and hypothyroidism
Use of NSAIDs
Insulin treatment
Taking antidepressants
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood suger. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;HbA1c. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;Lipid profile. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;Visfatin. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;Insulin. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.
- Secondary Outcome Measures
Name Time Method Fasting blood suger. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Hb A1c. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Lipid profile. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Visfatin. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Insulin. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.